Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015

Details for Mechanism ID: 16759
Country/Region: South Africa
Year: 2014
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $160,167 Additional Pipeline Funding: $365,796

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

The Paediatric Enhanced Surveillance Study (PESS) is actively enrolling and following a cohort of HIV-infected children newly initiated on ART at five health facilities in the Eastern Cape (EC) Province, South Africa (SA). The study provides insights into overall outcomes for the larger pediatric patient populations in the province and SA that will contribute to the improvement of care for children with HIV. The study examines clinical, immunologic, virologic, metabolic, psychosocial, and behavioral outcomes for up to 400 children who are newly initiated on ART. The study’s primary objective is to describe the demographic and clinical characteristics of children enrolled in HIV care and treatment at the study facilities. The records review is designed to describe: demographic and clinical characteristics of children enrolled in HIV C&T at the study facilities; proportion of the children enrolled in HIV C&T at the study facilities who start treatment and are retained in care (6, 12, 24, 36, 48 months); proportion of children LTFU after enrollment in care and in those starting treatment; first line regimens prescribed to children; and proportion of children with documented deaths and causes of deaths and time to death (from enrollment). This work is designed in collaboration with the provincial health authorities of the EC, ICAP-SA and CDC-SA in support of the South African National ART Program for Children. The study findings will be disseminated to the DOH at national and provincial levels as well as to providers to inform decision making at policy level. The ICAP and CDC study teams are monitoring study implementation progress (subject enrollment, adherence to the study protocol) and ensuring adherence to the protocol and ethical approvals.

Mechanism Allocation by Budget Code for Selected Year
Treatment: Pediatric Treatment (PDTX) $160,167
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

This mechanism has no published performance targets or indicators.